Volume 58, Issue 3 pp. 392-396
Original Article

Medication chart review at end of life of paediatric palliative patients

Jie Er Janice Soo

Jie Er Janice Soo

Ministry of Health Holdings, Singapore, Singapore

Search for more papers by this author
Mei Yoke Chan

Mei Yoke Chan

KK Women's and Children's Hospital, Singapore, Singapore

Search for more papers by this author
Noor Aisah Bee Bte Adb Rashid

Noor Aisah Bee Bte Adb Rashid

KK Women's and Children's Hospital, Singapore, Singapore

Search for more papers by this author
Lilis Irwani Bte Mohamad Yusri

Lilis Irwani Bte Mohamad Yusri

KK Women's and Children's Hospital, Singapore, Singapore

Search for more papers by this author
Yi Yi Wynn

Yi Yi Wynn

KK Women's and Children's Hospital, Singapore, Singapore

Search for more papers by this author
Misa Noda

Misa Noda

KK Women's and Children's Hospital, Singapore, Singapore

Search for more papers by this author
Komal Tewani

Corresponding Author

Komal Tewani

KK Women's and Children's Hospital, Singapore, Singapore

Correspondence: Dr Tewani Komal, KK Women's and Children's Hospital, 100 Bukit Timah Road, Singapore 229899. Fax: +65 629 8135; email: [email protected]

Search for more papers by this author
First published: 23 September 2021
Author contribution: Conception and design: K Tewani. Data collection: M Noda, Noor Aisah BBAR, Lilis BMY. Data analysis: JEJ Soo. Manuscript writing: JEJ Soo, K Tewani, MY Chan. Final approval of manuscript: All authors.

Conflict of interest: None.

Abstract

Aim

This study aimed to review the use of medications in a paediatric palliative care (PPC) population during the last two weeks of life.

Methods

This is a retrospective observational cohort study that included 50 consecutive patients who were referred to KK Hospital PPC service from 2011 to 2015. Those who died after two weeks from discharge date were excluded. Medication charts were reviewed and relevant data were extracted.

Results

The study population included 42 patients and consists predominantly oncological and neurological diagnoses. The median number of medications used was 11.5. Ninety-five percent (40 out of 42) of study population required analgesia where 81% (34 out of 42) were opioid. There was prevalent use of antibiotics (86% of study population, 36 out of 42). Less frequently used medications included steroids, sedatives, laxatives and antiemetics (48%, 52%, 48% and 38% of study population respectively).

Conclusion

Significant number of medications was used in PPC during the last two weeks of life. Apart from significant use of analgesia, there is also notable use of antibiotics. Future directions in education such as prescription of laxatives with opioid are proposed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.